Combining generative AI and quantum computing to accelerate drug discovery

Insilico Medicine, a clinical stage generative artificial intelligence (AI)-driven drug discovery company, today announced that it combined two rapidly developing technologies, quantum computing and generative AI, to explore lead candidate discovery in drug development and successfully demonstrated the potential advantages of quantum generative adversarial networks in generative chemistry.

Related Keywords

Toronto ,Ontario ,Canada ,Lily Ramsey ,Jimmy Yen Chu Lin ,Alex Zhavoronkov ,Hon Hai Foxconn Research Institute ,Acceleration Consortium ,University Of Toronto Acceleration Consortium ,University Of Toronto ,Generative Adversarial Networks Gans ,American Chemical Society ,Chemical Informinsilico Medicine ,Toronto Acceleration Consortium ,Hon Hai ,Zapata Computing ,Adversarial Networks ,Yen Chu Lin ,Insilico Medicine Taiwan ,Drug Discovery ,Medicine ,Artificial Intelligence ,Computational Modeling ,Olecule ,Research ,